纳布啡用于心脏病人非心脏手术后镇痛对心脏疾病的影响

目的：探讨纳布啡用于心脏病人镇痛（非心脏手术后）的影响。方法：选取2015年7月至2016年7月纳入的220例非心脏手术类型的心脏病患者，按随机数字表法分为对照组和治疗组，对照组采用芬太尼＋盐酸托烷司琼术后镇痛，治疗组则采用纳布啡十盐酸托烷司琼术后镇痛。对比两组的镇痛效果、术后并发症，心率及不良反应的差异。结果：两组镇痛效果相当，差异不显示出统计学的意义（P〉0．05）。术后并发症、心率、不良反应治疗组较时照组低，差异显示出统计学的意义（P〈0．05）。结论；纳布啡用于心脏病人镇痛（非心脏手术后）的临床疗效好，不良反应少，对心脏疾病影响低，是临床用于心脏病人镇痛（非心脏手术后）的良好选择。

Objective ：To investigate the effect of nalbupine on analgesia （after cardiac surgery） in patients with heart disease. Methods：A total of 220 patients with heart disease who were enrolled from July 2015 to July 2016 were randomly divided into control group and treatment group according to the random number table method. The control group was treated with fentanyl ＋ tropisetron hydrochloride Postoperative analgesia, the treatment group was treated with naftin ＋ tropisetron hydrochloride postoperative analgesia. Comparison of the two groups of analgesic effect, postoperative complications, heart rate and adverse reactions. Results：The analgesic effect of the two groups was similar, and the difference did not show statistical significance （P〉 0.05）. The postoperative complications, heart rate and adverse reaction were lower in the treatment group than in the control group （P 〈0.05）. Conclusion：Naphthyl is a good choice for cardiac patients with analgesia （noncardiac surgery） with good clinical efficacy, less adverse reactions and low heart disease. It is a good choice for clinical treatment of cardiac patients （noncardiac surgery）.